학술논문

145MO Updated survival, efficacy and safety of adjuvant (adj) atezolizumab (atezo) after neoadjuvant (neoadj) atezo in the phase II LCMC3 study
Document Type
Abstract
Source
In Journal of Thoracic Oncology April 2023 18(4) Supplement:S90-S91
Subject
Language
ISSN
1556-0864